Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Common Equity (2020 - 2025)

Beauty Health (SKIN) has disclosed Common Equity for 6 consecutive years, with $65.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Common Equity rose 9.94% to $65.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $65.7 million, a 9.94% increase, with the full-year FY2024 number at $51.8 million, down 12.77% from a year prior.
  • Common Equity was $65.7 million for Q3 2025 at Beauty Health, down from $74.0 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $345.4 million in Q2 2022 to a low of -$142.1 million in Q3 2021.
  • A 5-year average of $112.2 million and a median of $69.2 million in 2024 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: crashed 605620.03% in 2021, then soared 2049.38% in 2022.
  • Beauty Health's Common Equity stood at $298.0 million in 2021, then plummeted by 43.95% to $167.1 million in 2022, then tumbled by 64.45% to $59.4 million in 2023, then fell by 12.77% to $51.8 million in 2024, then grew by 26.75% to $65.7 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Common Equity are $65.7 million (Q3 2025), $74.0 million (Q2 2025), and $46.1 million (Q1 2025).